Skip to content

Effect of different general anesthesia combined with transverse abdominal muscle block on recovery quality after laparoscopic cholecystectomy

Effect of different general anesthesia combined with transverse abdominal muscle block on recovery quality after laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064707
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic cholecystectomy

Interventions

A group:Total intravenous anesthesia
B group:Total intravenous anesthesia + transverse abdominal muscle block
C group:Intravenous inhalation combined anesthesia
D group:Intravenous inhalation combined anesthesia + transverse abdominal muscle block

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA level I-II; 2. Age 18-65 years; 3. Patients undergoing cholecystectomy at a selected time.

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulation function; 2. Patients with infection or damage to the skin at the puncture site; 3. Individuals who are allergic to ropivacaine; 4. BMI30kg/m2; 5. Individuals with a history of chronic pain; 6. Have a history of long-term use of opioids and antipsychotic drugs; 7. Those with severe liver and kidney dysfunction; 8. Unable to accurately understand and express QoR40 and VAS scores.

Design outcomes

Primary

MeasureTime frame
QoR40 score;

Secondary

MeasureTime frame
Heart rate;Mean arterial pressure;VAS score;Spontaneous respiratory recovery time;Awakening time;Extubation time;PACU residence time;Hospitalization time;Remifentanil dosage;Time of the first salvage analgesia;Dosage of remedial analgesics;Antiemetic dosage;Adverse reactions such as nausea, vomiting and skin itching;

Countries

China

Contacts

Public ContactFangjun Wang

Affiliated Hospital of North Sichuan Medical College

wfjlxy006@126.com+86 13458253172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026